Prognostic Value of suPAR in HIV-1 Patients
Author Information
Author(s): Uffe V. Schneider, Rikke L. Nielsen, Court Pedersen, Jesper Eugen-Olsen
Primary Institution: Clinical Research Centre, Copenhagen University Hospital, Hvidovre, Denmark
Hypothesis
Elevated plasma suPAR levels indicate a heightened inflammatory state.
Conclusion
Plasma suPAR levels are strong predictors of survival in ART-naïve HIV-1 infected patients and are not influenced by uPAR promoter polymorphisms.
Supporting Evidence
- Survival was strongly correlated to suPAR levels.
- Patients with suPAR levels at or above 6 ng/ml had a higher mortality rate.
- The study identified two common uPAR promoter polymorphisms that did not influence suPAR levels or survival.
Takeaway
This study found that high levels of a protein called suPAR can help predict how long HIV patients might live, and that certain genetic changes don't affect this prediction.
Methodology
DNA and plasma samples were collected from HIV-1 infected individuals, and survival was analyzed using Kaplan Meier analysis.
Limitations
The study had a small sample size for some analyses, which may limit the generalizability of the findings.
Participant Demographics
145 HIV-1 infected Caucasians, 122 males with a mean seroconversion age of 32.0 years and 23 females with a mean age of 40.2 years.
Statistical Information
P-Value
p < 0.001
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website